Susquehanna International Group’s Mesa Laboratories MLAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-4,193
| Closed | -$281K | – | 13110 |
|
|
2025
Q3 | $281K | Sell |
4,193
-6,761
| -62% | -$487K | ﹤0.01% | 10279 |
|
|
2025
Q2 | $1.03M | Buy |
10,954
+3,863
| +54% | +$424K | ﹤0.01% | 7353 |
|
|
2025
Q1 | $841K | Buy |
7,091
+4,594
| +184% | +$626K | ﹤0.01% | 7686 |
|
|
2024
Q4 | $329K | Buy |
+2,497
| New | +$307K | ﹤0.01% | 9615 |
|
|
2024
Q3 | – | Sell |
-5,828
| Closed | -$506K | – | 12623 |
|
|
2024
Q2 | $506K | Buy |
+5,828
| New | +$610K | ﹤0.01% | 8242 |
|
|
2023
Q3 | – | Sell |
-2,296
| Closed | -$295K | – | 12588 |
|
|
2023
Q2 | $295K | Sell |
2,296
-142
| -6% | -$21.6K | ﹤0.01% | 9467 |
|
|
2023
Q1 | $426K | Buy |
+2,438
| New | +$437K | ﹤0.01% | 8961 |
|
|
2022
Q4 | – | Sell |
-2,114
| Closed | -$298K | – | 13191 |
|
|
2022
Q3 | $298K | Buy |
+2,114
| New | +$386K | ﹤0.01% | 9809 |
|
|
2022
Q1 | – | Sell |
-703
| Closed | -$231K | – | 13597 |
|
|
2021
Q4 | $231K | Buy |
+703
| New | +$221K | ﹤0.01% | 11125 |
|
|
2021
Q2 | – | Sell |
-1,595
| Closed | -$388K | – | 12991 |
|
|
2021
Q1 | $388K | Sell |
1,595
-613
| -28% | -$169K | ﹤0.01% | 10051 |
|
|
2020
Q4 | $633K | Buy |
+2,208
| New | +$607K | ﹤0.01% | 7767 |
|
|
2020
Q2 | – | Sell |
-1,242
| Closed | -$281K | – | 10602 |
|
|
2020
Q1 | $281K | Buy |
+1,242
| New | +$306K | ﹤0.01% | 8101 |
|
|
2019
Q4 | – | Sell |
-1,775
| Closed | -$422K | – | 10276 |
|
|
2019
Q3 | $422K | Sell |
1,775
-6,620
| -79% | -$1.53M | ﹤0.01% | 7654 |
|
|
2019
Q2 | $2.05M | Buy |
8,395
+7,298
| +665% | +$1.7M | ﹤0.01% | 4123 |
|
|
2019
Q1 | $253K | Sell |
1,097
-3,156
| -74% | -$713K | ﹤0.01% | 7510 |
|
|
2018
Q4 | $886K | Buy |
4,253
+2,118
| +99% | +$413K | ﹤0.01% | 4917 |
|
|
2018
Q3 | $396K | Sell |
2,135
-924
| -30% | -$186K | ﹤0.01% | 6941 |
|
|
2018
Q2 | $646K | Buy |
+3,059
| New | +$535K | ﹤0.01% | 6299 |
|
|
2018
Q1 | – | Sell |
-9,502
| Closed | -$1.18M | – | 9839 |
|
|
2017
Q4 | $1.18M | Buy |
9,502
+2,603
| +38% | +$364K | ﹤0.01% | 4903 |
|
|
2017
Q3 | $1.03M | Buy |
+6,899
| New | +$973K | ﹤0.01% | 5218 |
|
|
2017
Q1 | – | Sell |
-5,710
| Closed | -$701K | – | 9556 |
|
|
2016
Q4 | $701K | Buy |
+5,710
| New | +$713K | ﹤0.01% | 6277 |
|
|
2015
Q3 | – | Sell |
-2,765
| Closed | -$246K | – | 9944 |
|
|
2015
Q2 | $246K | Buy |
+2,765
| New | +$234K | ﹤0.01% | 8915 |
|
Other funds holding MLAB
LPP
RIM
GCM
RA
KCM
Susquehanna International Group's MLAB Position: Q4 2025 in Review
Susquehanna International Group sold out of Mesa Laboratories (MLAB) in Q4 2025, closing a stake of 4,193 shares — an estimated $281K sold.
Susquehanna International Group first reported a position in MLAB in Q2 2015 and held it in 22 quarters. The position peaked at $2.05M in Q2 2019. 159 funds tracked by Wall St. Rank hold MLAB as of Q4 2025.
- Susquehanna International Group reported no remaining Mesa Laboratories position as of Q4 2025 after selling out during the quarter.
- Susquehanna International Group sold 4,193 Mesa Laboratories shares in Q4 2025, an estimated $281K.
- Susquehanna International Group first reported a position in Mesa Laboratories in Q2 2015 and held it in 22 quarters.
- Susquehanna International Group's Mesa Laboratories position peaked at $2.05M in Q2 2019.
- 159 funds tracked by Wall St. Rank held Mesa Laboratories as of Q4 2025.
Based on Susquehanna International Group's 13F filing for Q4 2025, filed 17 Feb 2026.